Elizabeth Tsurkov, a Russian-Israeli doctoral student at Princeton University, was conducting research in Baghdad in 2023 when she was kidnapped by an Iran-linked militia and held in captivity for more than 900 days. Her release last September followed a high-stakes international push. Amna Nawaz speaks with Tsurkov for her first American television interview. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy
It's a celebration as well as a reckoning: After seven years, the Studio Museum in Harlem reopened this fall in a new building that showcases its history of highlighting Black artists. It's a history and project credited with helping change and diversify the art world. Senior arts correspondent Jeffrey Brown visited the museum for our arts and culture series, CANVAS. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy
David Greene joins us to talk about his new podcast, David Greene Is Obsessed, where opera singers map public restrooms, pizza-tour guys chase the perfect slice, and even David Arquette turns Bozo the Clown into an intellectual-property saga. We get into why an obsession can unlock a different kind of interview, plus Greene's own confessions, from the Hay-Adams bathroom workaround to sports fandom. Plus: the Mississippi miracle, and what China's van-based math prodigies say about how serious nations approach the future. And in the Spiel, life expectancy hits 79 in 2024, why that stat misleads even when it's true, and why good news gets swamped by the bad stuff.
P.M. Edition for Feb. 2. Even as home sales remain stuck at a 30-year low, people that are buying are finding big discounts. WSJ reporter Nicole Friedman discusses the changing dynamics in the market. Plus, the partial government shutdown means Friday’s jobs report will be delayed. We hear from Journal economics reporter Matt Grossman about what that means for investors. And a Michigan pension fund lost millions on an investment in a coffee farm. As reporter Heather Gillers tells us, what happened there highlights the risks that come with investing in private markets. Alex Ossola hosts.
The Rafah crossing reopens between Gaza and Egypt. Are enough Palestinians in urgent need of medical treatment able to use it? We hear from the family of one injured boy.
Also on the programme: the detention of a five-year-old in an immigration raid in Minnesota enrages a judge; and why seeing the iconic Trevi Fountain in Rome is now going to cost you.
(Photo: A Palestinian patient, accompanied by relatives, waits to leave Gaza for treatment abroad through the Rafah border crossing between Gaza and Egypt. Credit: Reuters)
The Justice Department says their review into convicted sex offender Jeffrey Epstein is done, with the release of millions of documents and thousands of images and videos last Friday.
Annie Farmer is one of many people who testified in court about Epstein, and Ghislaine Maxwell. She says they sexually abused her when she was 16 years old.
She's also been a leading voice in calling on the DOJ to release all records related to Epstein.
The release included pictures of nude women, or possibly girls, and the names of victims, all of which should have been redacted. A DOJ spokeswoman subsequently told the New York Times the department was addressing victim concerns and making additional redactions.
Farmer tells NPR she's "really upset," saying the release of victims' names and images is "really disgusting." However she adds that, "what I do feel clear about is the fact we still believe transparency is important."
For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org. Email us at considerthis@npr.org.
This episode was produced by Jonaki Mehta and Karen Zamora, with audio engineering by Ted Mebane. It was edited by Sarah Handel.
Plus: The Trump administration is preparing a $12 billion rare earth stockpile. And Saks Fifth Avenue’s parent company to wind down its partnership with Amazon. Julie Chang hosts.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Big pharma and biotech take the earnings stage this week with reports from Eli Lilly (NYSE: LLNY) and Novo Nordisk (NYSE: NVO) leading the lineup. Will they help the industry once again outperform AI champ NVIDIA (NASDAQ: NVDA), as the industry did in 2025?
Karl Thiel, Tom King, and Tim Beyers discuss:
- Slow rolling chaos at FDA and its effects on drug approvals.
- How to think about risk when investing in biotech.
- Earnings predictions for Lilly and Novo as well as a review of results from DNA researcher Twist Bioscience (NASDAQ: TWST).
Don’t wait! Be sure to get to your local bookstore and pick up a copy of David’s Gardner’s new book — Rule Breaker Investing: How to Pick the Best Stocks of the Future and Build Lasting Wealth. It’s on shelves now; get it before it’s gone!
Companies discussed: RGNX, LLY, NVO, TWST
Host: Tim Beyers
Guests: Karl Thiel, Tom King
Producer: Anand Chokkavelu
Engineer: Dan Boyd
Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement.
We’re committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode.
Learn more about your ad choices. Visit megaphone.fm/adchoices
